BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 16624894)

  • 1. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
    Halldórsdóttir AM; Zhang L; Tollefsen DM
    Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
    Maimone MM; Tollefsen DM
    J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis.
    Volpi N; Maccari F
    Glycobiology; 2009 Apr; 19(4):356-67. PubMed ID: 19056786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
    Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
    Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative influence of different disulphate disaccharide clusters on the HCII-mediated inhibition of thrombin by dermatan sulphates of different origins.
    Mascellani G; Liverani L; Prete A; Guppola PA; Bergonzini G; Bianchini P
    Thromb Res; 1994 Jun; 74(6):605-15. PubMed ID: 8091403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate.
    Mascellani G; Liverani L; Bianchini P; Parma B; Torri G; Bisio A; Guerrini M; Casu B
    Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):639-48. PubMed ID: 8280062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of dermatan sulfate active site for heparin cofactor II by 1H nuclear magnetic resonance spectroscopy.
    Mascellani G; Liverani L; Prete A; Bergonzini G; Bianchini P; Torri G; Bisio A; Guerrini M; Casu B
    Anal Biochem; 1994 Nov; 223(1):135-41. PubMed ID: 7695089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula).
    Ben Mansour M; Dhahri M; Bertholon I; Ollivier V; Bataille I; Ajzenberg N; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Thromb Res; 2009 Apr; 123(6):887-94. PubMed ID: 19019412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
    Tollefsen DM
    Adv Exp Med Biol; 1992; 313():167-76. PubMed ID: 1442260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities.
    Du HY; Ji SL; Song HF; Ye QN; Cao JC
    Thromb Res; 2007; 119(3):377-84. PubMed ID: 17097136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identity of dermatan and chondroitin sequences in dermatan sulfate chains determined by using fragmentation with chondroitinases and ion-pair high-performance liquid chromatography.
    Karamanos NK; Vanky P; Syrokou A; Hjerpe A
    Anal Biochem; 1995 Mar; 225(2):220-30. PubMed ID: 7762784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique dermatan sulfate-like glycosaminoglycan from ascidian. Its structure and the effect of its unusual sulfation pattern on anticoagulant activity.
    Pavão MS; Mourão PA; Mulloy B; Tollefsen DM
    J Biol Chem; 1995 Dec; 270(52):31027-36. PubMed ID: 8537360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
    Tollefsen DM; Peacock ME; Monafo WJ
    J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of glycosaminoglycans with heparin cofactor II.
    Tollefsen DM
    Ann N Y Acad Sci; 1994 Apr; 714():21-31. PubMed ID: 8017769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of oligosaccharides from the chondroitin/dermatan sulfates. 1H-NMR and 13C-NMR studies of reduced trisaccharides and hexasaccharides.
    Huckerby TN; Nieduszynski IA; Giannopoulos M; Weeks SD; Sadler IH; Lauder RM
    FEBS J; 2005 Dec; 272(24):6276-86. PubMed ID: 16336265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues.
    Osborne SA; Daniel RA; Desilva K; Seymour RB
    Glycobiology; 2008 Mar; 18(3):225-34. PubMed ID: 18156656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of oligomeric domains within dermatan sulfate chains using differential enzymic treatments, derivatization with 2-aminoacridone and capillary electrophoresis.
    Mitropoulou TN; Lamari F; Syrokou A; Hjerpe A; Karamanos NK
    Electrophoresis; 2001 Aug; 22(12):2458-63. PubMed ID: 11519950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein.
    Calabrese GC; Alberto MF; Tubio R; Marani MM; Fernández De Recondo ME; Lazzari M; Recondo EF
    Thromb Res; 2004; 113(3-4):243-50. PubMed ID: 15140589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatan sulfate in tunicate phylogeny: order-specific sulfation pattern and the effect of [→4IdoA(2-sulfate)β-1→3GalNAc(4-sulfate)β-1→] motifs in dermatan sulfate on heparin cofactor II activity.
    Kozlowski EO; Lima PC; Vicente CP; Lotufo T; Bao X; Sugahara K; Pavão MS
    BMC Biochem; 2011 May; 12():29. PubMed ID: 21619699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
    Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
    Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.